NHI.no
Annonse
Informasjon

Diabetisk fotsår

Diabetiske fotsår er vanlig hos pasienter som har hatt diabetes i flere år. God blodsukkerkontroll reduserer risikoen for fotsår.

Diabetisk fotsår er en risiko ved langvarig diabetes. Gode rutiner for sjekk av føttene kan forebygge alvorlige sår.

Sist oppdatert:

17. mars 2020

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Diabetisk fotsår . Referanselisten for dette dokumentet vises nedenfor

  1. Robberstad M, Bentsen SB, Berg TJ, Iversen MM. Diabetiske fotsårteam i norske sykehus. Tidsskr Nor Legeforen 2017. pmid:28925190 PubMed
  2. Helsedirektoratet. Nasjonale faglig retningslinje for diabetes. Oslo; Helsedirektoratet 2019. helsedirektoratet.no
  3. Molvær AK, Graue M, Espehaug B, et al. Diabetes-related foot ulcers and associated factors: results from the Nord-Trøndelag Health Survey (HUNT3) (2006-2008). J Diabetes Complications 2014; 28: 156 - 61. PMID: 24360341 PubMed
  4. Iversen MM, Midthjell K, Østbye T, et al. History of and factors associated with diabetic foot ulcers in Norway: the Nord-Trøndelag Health Study. Scand J Public Health 2008; 36: 62 - 8. PMID: 18426786 PubMed
  5. Helsedirektoratet. Nasjonale kvalitetsindikatorer. Diabetes - amputasjoner blant pasienter med diabetes. Sist oppdatert 30.11.2023. Siden lest 28.01.2024 www.helsedirektoratet.no
  6. Watkins PJ. ABC of diabetes. The diabetic foot. BMJ 2003; 326: 977-9. PubMed
  7. Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442-7. PubMed
  8. The International Working Group on the Diabetic Foot. Praktiske retningslinjer - den diabetiske fot. WHO-retningslinjer for behandling av den diabetiske fot omarbeidet til norsk. 1. Oslo: Norsk interessefaggruppe for sårheling og Norges Diabetesforbund, 2001.
  9. Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med 2000; 17: 253-8. PubMed
  10. Gürgen M, Kaal A, Witsø E. Diabetiske fotsår. Tidsskr Nor Lægeforen 2005; 125: 899-902. PubMed
  11. Helsedirektoratet (2021). Nasjonal faglig retningslinje for antibiotika i primærhelsetjenesten nettdokument. Oslo: Helsedirektoratet (sist faglig oppdatert 16. november 2021, lest jan 2022).
  12. Frykberg RG, Franks PJ, Edmonds M, et al. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study. Diabetes Care 2019. pmid:31619393 PubMed
  13. Lewis J, Lipp A. Pressure‐relieving interventions for treating diabetic foot ulcers. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD002302. DOI: 10.1002/14651858.CD002302.pub2. Accessed 28 February 2024. The Cochrane Library
  14. Armstrong DG, et al. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005; 28: 551-4. PubMed
  15. Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD003556. DOI: 10.1002/14651858.CD003556.pub2. Accessed 28 February 2024. The Cochrane Library
  16. Dumville JC, Lipsky BA, Hoey C, et al. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017 Jun 14;6:CD011038. PMID: 28613416 PubMed
  17. Armstrong DG, Nguyen HC. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes. Arch Surg 2000; 135: 1405-9. PubMed
  18. Huang Y-Y, Lin C-W, Cheng N-C, et al. Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers A Randomized Clinical Trial. JAMA Netw Open 2021. doi:10.1001/jamanetworkopen.2021.22607 DOI
  19. NSAMs referansegruppe for diabetes. NSAMs handlingsprogram for diabetes i allmennpraksis. 2005.
  20. O'Reilly D, Pasricha A, Campbell K, et al. Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis. Int J Technol Assess Health Care. 2013;29(3):269-81. doi: 10.1017/S0266462313000263. DOI
  21. Liu R, Li L, Yang M, et al. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 2013 Feb;88(2): 166-75. doi: 10.1016/j.mayocp.2012.10.021. DOI
  22. Fedorko L, Bowen JM, Jones W, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: A prospective, double-blind, randomized controlled clinical trial. Diabetes Care 2016; 39: 392-99. doi:10.2337/dc15-2001 DOI
  23. Santema KTB, Stoekenbroek RM, Koelemay MJW, Reekers J. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care. 2017. PMID: 29074815 PubMed
  24. Santema TB, Poyck PPC, Ubbink DT. Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD011255. DOI: 10.1002/14651858.CD011255.pub2 DOI
  25. Moore ZE, Corcoran MA, Patton D Nutritional interventions for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2020 Jul 17;7:CD011378. doi: 10.1002/14651858.CD011378.pub2. DOI
  26. Boyko EJ, Zelnick LR, Braffet B, et al. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2022; 45: 357-364. pmid:35007329 PubMed
Annonse
Annonse